6-K/A

AMENDMENT NO. 1 TO FORM 6-K

Company: XTL BIOPHARMACEUTICALS LTD
Filed: June 18, 2025
Period of Report: June 18, 2025
Accession Number: 0001213900-25-055693

View Document ↗ View on SEC.gov ↗